CA2168885A1 - Compositions pour vaccins - Google Patents
Compositions pour vaccinsInfo
- Publication number
- CA2168885A1 CA2168885A1 CA002168885A CA2168885A CA2168885A1 CA 2168885 A1 CA2168885 A1 CA 2168885A1 CA 002168885 A CA002168885 A CA 002168885A CA 2168885 A CA2168885 A CA 2168885A CA 2168885 A1 CA2168885 A1 CA 2168885A1
- Authority
- CA
- Canada
- Prior art keywords
- vaccine compositions
- vaccine composition
- hepatitis
- mucosal
- epitope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 241000709721 Hepatovirus A Species 0.000 abstract 1
- 210000000234 capsid Anatomy 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 208000005252 hepatitis A Diseases 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 229940027941 immunoglobulin g Drugs 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939316745A GB9316745D0 (en) | 1993-08-12 | 1993-08-12 | Vaccine compositions |
GB9316745.0 | 1993-08-12 | ||
PCT/GB1994/001646 WO1995005194A1 (fr) | 1993-08-12 | 1994-07-29 | Composition vaccinale |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2168885A1 true CA2168885A1 (fr) | 1995-02-23 |
CA2168885C CA2168885C (fr) | 2007-05-15 |
Family
ID=38069004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002168885A Expired - Fee Related CA2168885C (fr) | 1993-08-12 | 1994-07-29 | Compositions pour vaccins |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2168885C (fr) |
-
1994
- 1994-07-29 CA CA002168885A patent/CA2168885C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2168885C (fr) | 2007-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2132547A1 (fr) | Vaccins renfermant des vesicules d'agents tensioactifs non ioniques | |
WO1988008718A1 (fr) | Immunisation intranasale contre une infection virale, utilisant un vaccin de sous-unite de glycoproteine virale | |
EP0992580A3 (fr) | Epitopes de lymphocytes T humains immunodominants du virus de l'hépatite C | |
PT101052A (pt) | Proteinas hibridas uteis na preparacao de vacinas | |
CA2078694A1 (fr) | Vaccin contre l'hepatite b | |
EP0090581A3 (fr) | Petits peptides specifiques des antigènes de la fièvre aphteuse | |
EP0263761A3 (fr) | Antigène d'hépatite non-A non-B | |
GB9316745D0 (en) | Vaccine compositions | |
AU3705793A (en) | Mutant respiratory syncytial virus (RSV), vaccines containing same and methods of use | |
AU8010791A (en) | Hiv monoclonal antibody | |
KR920004422A (ko) | Hiv의 주요 중화 결정인자 | |
CA2168885A1 (fr) | Compositions pour vaccins | |
US4584195A (en) | Broad spectrum vaccine against gonorrhea | |
US5449765A (en) | DNA encoding amino acids 590-710 of glycoprotein gII of pseudorabies virus | |
AU6461594A (en) | Induction of protection against viral infection | |
US4622223A (en) | Broad spectrum vaccine against gonorrhea | |
CA2160696A1 (fr) | Peptides utiles pour la vaccination et l'induction d'anticorps neutralisateurs contre le virus de l'immunodefience humaine | |
CA2072982A1 (fr) | Vaccins contre l'hepatite a | |
EP0250128A3 (fr) | Virus isolé de patients atteints du SIDA | |
CA2304255A1 (fr) | Polypeptides du virus de l'hepatite b | |
HK167295A (en) | Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens | |
ATE204761T1 (de) | Pharmazeutische antigen-/antikörperpräparation | |
WO2000006197A8 (fr) | Vaccin combine d'immunoprophylaxie contre l'hepatite b et d virale, le tetanos et la diphterie | |
AU2713488A (en) | Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |